Cooperation Agreements in the Pharmaceuticals Industry
19 Contracts & Agreements
- Assertio Therapeutics, Inc (1 contract)
- Biostar Pharmaceuticals, Inc. (3)
- Cerecor Inc. (1)
- COLLAGENEX PHARMACEUTICALS INC (1)
- Elanco Animal Health Inc (1)
- Liquidia Corp (2)
- Mallinckrodt (1)
- Marijuana Co of America, Inc. (1)
- Milestone Pharmaceuticals Inc. (0)
- OptiNose, Inc. (2)
- SUNWIN STEVIA INTERNATIONAL, INC. (1)
- TAURIGA SCIENCES, INC. (1)
- Theravance Biopharma, Inc. (1)
- Urovant Sciences Ltd. (2)
- Zomedica Pharmaceuticals Corp. (1)
- Cooperation Agreement, dated as of March 29, 2024, by and among Elanco Animal Health Incorporated, Ancora Catalyst Institutional, LP and the other person and entities listed... (Elanco Animal Health Inc, Filed With SEC on April 1, 2024)
- Final Amendment to the Opioid MDT II Cooperation Agreement, dated as of August 23, 2033, by and among Mallinckrodt Plc, its undersigned affiliates and the Opioid Master... (Mallinckrodt, Filed With SEC on November 7, 2023)
- Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors... (OptiNose, Inc., Filed With SEC on May 12, 2022)
- Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors... (OptiNose, Inc., Filed With SEC on April 26, 2022)
- Cooperation Agreement, dated as of November 4, 2021, by and between Avalo Therapeutics, Inc. and Armistice Capital, LLC (Cerecor Inc., Filed With SEC on November 9, 2021)
- Cooperation Agreement: Salinas Diversified Ventures, Inc. & VBF Brands, Inc., Sunset Island Group, Inc. & Lori Livacich (Marijuana Co of America, Inc., Filed With SEC on October 13, 2021)
- Cooperation Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc. and Serendipity BioPharma LLC, dated as of June 29, 2020 (Liquidia Corp, Filed With SEC on August 5, 2020)
- Cooperation Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., PBM Capital Finance, LLC and PD Joint Holdings, LLC Series 2016-A, dated as of June 29, 2020 (Liquidia Corp, Filed With SEC on August 5, 2020)
- Cooperation Agreement among Theravance Biopharma, Inc., GSK Finance (No.3) plc and GlaxoSmithKline plc dated June 22, 2020 (Theravance Biopharma, Inc., Filed With SEC on June 25, 2020)
- Information Sharing and Cooperation Agreement, dated May 21, 2020, by and between Urovant Sciences, Ltd. and Sumitovant Biopharma Ltd (Urovant Sciences Ltd., Filed With SEC on May 28, 2020)
- Cooperation Agreement between the Company and Gerald Solensky, Jr. dated December 2, 2019 (Zomedica Pharmaceuticals Corp., Filed With SEC on December 3, 2019)
- Information Sharing and Cooperation Agreement, dated as of July 9, 2018, by and between Roivant Sciences Ltd. and the Registrant (Urovant Sciences Ltd., Filed With SEC on July 13, 2018)
- COOPERATION AND SUPPORT AGREEMENT (Assertio Therapeutics, Inc, Filed With SEC on March 29, 2017)
- Cooperation Agreement (Translation) (SUNWIN STEVIA INTERNATIONAL, INC., Filed With SEC on July 30, 2012)
- Novo Energies Corporation 750 Cote de Place d'Armes, Suite #64 Montreal QC H2Y 2X8 Canada ###-###-#### eFax: 1 ###-###-#### Technology Co-Operation Agreement between Novo Energies... (TAURIGA SCIENCES, INC., Filed With SEC on June 21, 2010)
- Cooperation Agreement (Biostar Pharmaceuticals, Inc., Filed With SEC on May 9, 2008)
- Cooperation Agreement (Biostar Pharmaceuticals, Inc., Filed With SEC on May 9, 2008)
- Cooperation Agreement (Biostar Pharmaceuticals, Inc., Filed With SEC on May 9, 2008)
- EXTENSION AND AMENDMENTTO PROMOTION AND COOPERATION AGREEMENT (COLLAGENEX PHARMACEUTICALS INC, Filed With SEC on March 16, 2007)
